Programme will be announced soon

This year Scientific Programme includes the following topics and speakers:

MAKE IT UNBREAKABLE! COVALENT APPROACH IN DRUG DISCOVERY

Alessio LODOLA, University of Parma (IT)
“Models for the discovery of covalent inhibitors”

Chiara BORSARI, University of Milan (IT)
“Integration of Medicinal Chemistry and Chemical Biology in the Development of Covalent Chemical Probes”

Annamaria MARTORANA, University of Palermo (IT)
“Targeting Sars-Cov-2 Main protease in the treatment of COVID-19: focus on covalent inhibition”

Francesco CASUSCELLI, Nerviano Medical Sciences Srl (IT)
“Leveraging Covalent Approaches for the Discovery and Drug Development of Dual IDH1/2 Second Generation Inhibitors”

CLICK-AND-TAG: HOW BIOORTHOGONAL CHEMISTRY IS TRANSFORMING DRUG DISCOVERY

Helen OSBORN, University of Reading (UK)
“Designing chemical reactions for use in living systems: the role of bioorthogonal chemistry”

Anja PALMANS, Eindhoven University of Technology (NL)
“Bioorthogonal catalysis for medicinal chemistry applications”

Frédéric TARAN, Paris-Saclay University (FR)
“In vivo chemistry for diagnostic and therapeutic applications”

Milan VRABEL, Institute of Organic Chemistry and Biochemistry of the Czech Academi of Sciences (CZ)
“Developing new bioorthogonal reactions: Expanding the toolbox for biomedical research”

UNUSUAL ELEMENTS AND FUNCTIONAL GROUPS SHAPING THE FUTURE OF MEDICINAL CHEMISTRY

Evamarie HEY-HAWKINS, Leipzig University (DE)
“Carborane-Containing Drugs: New Keys for Old Locks”

Jack ROWBOTHAM, University of Manchester (UK)
“Meeting the Challenges of Heavy Drug Synthesis with Biocatalytic Asymmetric Deuteration”

Gian Cesare TRON, University of Piemonte Orientale (IT)
“Lost and found: (Re)discovering the Potential of Neglected Functional Groups in Medicinal Chemistry. A Focus on Isocyanides”

Mauro ADAMO, University of Medicine and Health Science, Dublin (IE)
“Introduction of Fluorine on Small and Large Molecules: Opportunities for Drug Discovery and Lead development”

Market Watch: New Drug Approval in 2023 and Synthetic Strategies

Tiziano BANDIERA, Istituto Italiano di Tecnologia, Genova (IT)